Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Changhai Hospital
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
H. Lee Moffitt Cancer Center and Research Institute
Melanoma Institute Australia
Wake Forest University Health Sciences
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Columbia University
The First Affiliated Hospital of Guangzhou Medical University
Thomas Jefferson University
Washington University School of Medicine
Haydarpasa Numune Training and Research Hospital
Jagiellonian University
Sichuan Cancer Hospital and Research Institute
Melanoma and Skin Cancer Trials Limited
Krankenhaus Nordwest
Erasmus Medical Center
University of California, San Francisco
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
UNC Lineberger Comprehensive Cancer Center
Nanchang University
Hospital Universitari de Bellvitge
Nova Scotia Health Authority
Peking University First Hospital
Columbia University
University of Birmingham
Fujian Medical University
First Affiliated Hospital, Sun Yat-Sen University
Emory University
National Cancer Centre, Singapore
Istanbul Medeniyet University
The University of Texas Health Science Center at San Antonio
West China Hospital
Swiss Cancer Institute
Goethe University
Universitätsklinikum Hamburg-Eppendorf
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nanfang Hospital, Southern Medical University
Fujian Maternity and Child Health Hospital
Shanghai Zhongshan Hospital
Loma Linda University
Mansoura University
Universitätsklinikum Hamburg-Eppendorf
University of Ulm
Medical University of Vienna
Washington University School of Medicine
M.D. Anderson Cancer Center
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Jagiellonian University
H. Lee Moffitt Cancer Center and Research Institute